Author:
Soo Patrick Lim,Dunne Michael,Liu Jubo,Allen Christine
Reference177 articles.
1. Abraham, S. A.; Waterhouse, D. N.; Mayer, L. D.; Cullis, P. R.; Madden, T. D.; Bally, M. B., The liposomal formulation of doxorubicin. Liposomes, Pt E, 2005; Vol. 391, pp 71–97.
2. Adams, M. L.; Kwon, G. S., Relative aggregation state and hemolytic activity of amphotericin B encapsulated by poly(ethylene oxide)-block-poly(N-hexyl-L-aspartamide)-acyl conjugate micelles: effects of acyl chain length. Journal of Controlled Release 2003, 87, (1–3), 23–32.
3. Adams, M. L.; Lavasanifar, A.; Kwon, G. S., Amphiphilic block copolymers for drug delivery. Journal of Pharmaceutical Sciences 2003, 92, (7), 1343–55.
4. Alakhov, V., Polymer-Based Nanomedicines for Oncology: From Preclinical Studies to the Clinical Proof of the Concept. In 4th International Nanomedicine and Drug Delivery Symposium, Omaha, Nebraska, US, 2006.
5. Alakhov, V., Klinski, E., Li, S., Pietrzynski, G., Venne, A., Batrakova, E., Bronitch, T., and Kabanov, A., Block copolymer-based formulation of doxorubicin. From cell screen to clinical trials. Colloids and Surfaces B: Biointerfaces 1999, 16, 113–134.
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献